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Abstract 22 
Viral hemorrhagic septicemia virus (VHSV) is one of the major threats to the development of the 23 
aquaculture industry worldwide. The present study was aimed to identify genes differentially expressed in 24 
several turbot (Scophthalmus maximus) families showing different mortality rates after VHSV. The 25 
expression analysis was conducted through genome-wide expression profiling with an oligo-microarray in 26 
the head-kidney. A significant proportion of the variation in the gene expression profiles seemed to be 27 
explained by the genetic background, indicating that the mechanisms by which particular species and/or 28 
populations can resist a pathogen(s) are complex and multifactorial. Before the experimental infections, 29 
fish from resistant families (low mortality rates after VHSV infection) showed high expression of 30 
different antimicrobial peptides, suggesting that their pre-immune state may be stronger than fish of 31 
susceptible families (high mortality rates after VHSV infection). After infection, fish from both high- and 32 
low-mortality families showed an up-modulation of the interferon-induced Mx2 gene, the IL-8 gene and 33 
the VHSV-induced protein 5 gene compared with control groups. Low levels of several molecules 34 
secreted in the mucus were observed in high-mortality families, but different genes involved in viral 35 
entrance into target cells were down-regulated in low-mortality families. Moreover, these families also 36 
showed a strong down-modulation of marker genes related to VHSV target organs, including biochemical 37 
markers of renal dysfunction and myocardial injury. In general, the expression of different genes involved 38 
in the metabolism of sugars, lipids and proteins were decreased in both low- and high-mortality families 39 
after infection. The present study serves as an initial screen for genes of interest and provides an extensive 40 
overview of the genetic basis underlying the differences between families that are resistant or susceptible 41 
to VHSV infection. 42 
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55 
Introduction 56 
Viral hemorrhagic septicemia virus (VHSV) is one of the most serious pathogens of finfish worldwide 57 
in terms of its wide host range, pathogenicity, disease course and mortality rate (Smail 1999). VHSV is 58 
thus one of the main threats to the development of the aquaculture industry worldwide. In general, this 59 
virus causes severe necrosis in the hematopoietic tissues of affected fish (Yasutake 1975). Although 60 
VHSV has historically been considered a disease of farmed rainbow trout (Oncorhynchus mykiss) in 61 
continental Europe, the host range appears to be broad, and several marine fish species have now been 62 
reported to carry VHSV, including turbot (Scophthalmus maximus) (Ross et al. 1994; Schlotfeld et al. 63 
1991). In fact, Tafalla et al. (1998) reported that VHSV is able to replicate in turbot blood leukocytes and 64 
kidney macrophages. 65 
Although there have been several attempts to develop traditional vaccines against viral diseases based 66 
on inactivated or attenuated viruses, the protective effect of these vaccines has been limited or 67 
inconsistent (Lorenzen and Olesen 1997; Winton 1997). The most efficient vaccines against VHSV to 68 
date have been DNA vaccines using the viral G glycoprotein (Lorenzen et al. 2001, 2002a, 2002b, 2005). 69 
However, many consumers do not understand the difference between DNA-vaccinated animals and a 70 
genetically modified organism (GMO), and the use of DNA vaccines is still problematic for fish farmers. 71 
Therefore, a better understanding of the host immune response is required to develop a more efficient 72 
means of VHSV prevention and treatment.  73 
Improving infectious disease resistance by genetic means is an attractive alternative approach because 74 
of its prospects for prolonged, sustained protection. There are several strong indications that genetic traits 75 
are involved in the resistance of rainbow trout (O. mykiss) against VHSV (Jørgensen et al. 2011). Using 76 
gynogenesis, it has been possible to obtain highly resistant families of trout after only two generations 77 
(Dorson et al. 1995; Slierendrecht et al. 1995). The finding that only a few generations seem to be 78 
required to obtain highly resistant or highly susceptible families of offspring may further indicate that 79 
only a few genes play a major role. However, the underlying mechanisms of the observed resistance 80 
differences are not known, and only a limited number of studies have investigated this topic to date. 81 
Attempts to identify the mechanism of resistance against VHSV have focused on allelic variations of the 82 
complement component C3 and MHC between resistant and susceptible families of rainbow trout, but 83 
these attempts have not been successful (Slierendrecht et al. 1996, 2001). Moreover, a genome-wide 84 
analysis of families of trout with different susceptibility to VHSV has recently been published (Jørgensen 85 
et al. 2011). However, the basis of this genetically determined VHS resistance has yet to be elucidated. A 86 
global understanding of the changes in the expression of host cell genes after viral infection should 87 
improve our understanding of the virus/host cell interactions. 88 
Despite the great number of reports in which microarrays have been used to study complex biological 89 
mechanisms in fish at the genomic level, few studies have focused on global gene expression in immune 90 
cells after VHSV challenge. Only two fish species, the Japanese flounder (Paralichthys olivaceus) (Aoki 91 
et al. 2011; Byon et al. 2005, 2006) and the zebrafish (Danio rerio) (Encinas et al. 2010), have been 92 
studied in this manner.  93 
The present study aimed to identify genes that are differentially expressed in low- and high-mortality 94 
families of turbot during VHSV infection by genome-wide expression profiling with microarrays. This 95 
characterization could identify genes that constitute relevant VHSV resistance markers and help prioritize 96 
candidates of interest for further functional and genetic (e.g. searches for quantitative trait loci) studies. 97 
To our knowledge, this is the first report on the global transcriptional response to VHSV infection in 98 
turbot.  99 
 100 
Materials and methods 101 
Cell culture and virus 102 
The epithelioma papulosum cyprinid (EPC) fish cell line, derived from common carp (Cyprinus 103 
carpio L.) (Tomasec and Fijan 1971), was obtained from the European collection of cell cultures 104 
(ECACC no. 93120820) and used in this work. EPC cells were maintained at 20 ºC in Eagle’s minimum 105 
essential medium (MEM; Invitrogen, GIBCO) containing 10% foetal bovine serum (FBS; Invitrogen, 106 
GIBCO), penicillin (100 IU/ml) (Invitrogen, GIBCO), and streptomycin (100 µg/ml) (Invitrogen, 107 
GIBCO), buffered with 7.5% sodium bicarbonate (Invitrogen, GIBCO). 108 
VHSV strain UK 860-94, isolated from turbot in Scotland (S. maximus) (Ross et al. 1994), was used 109 
for the experimental infections. The virus was replicated in EPCs grown in MEM with antibiotics and 2% 110 
FBS at 14 ºC. When the cytopathic effect became extensive, the supernatant was harvested and 111 
centrifuged to eliminate cell debris. Clarified supernatants were then used for subsequent experiments. 112 
The virus stock was titrated in 96-well plates according to Reed and Müench (1938). 113 
 114 
Fish  115 
Six different families of turbot (S. maximus) were obtained from a commercial fish farm (Stolt Sea 116 
Farm S.A.) in Spain. A total of 120 juvenile fish (3 g mean) per family were stocked in 400 l tanks. Fish 117 
were acclimatized to laboratory conditions for 2 weeks prior to the experiments. No clinical signs were 118 
ever observed during this period. Fish were maintained at 16.5 (± 2) ºC with aeration and fed daily with 119 
commercial dry pellet food (Skretting).  120 
 121 
Experimental infections 122 
Fish from each of the six families were divided into four groups containing 50 l of static UV-treated 123 
seawater. The fish were lightly anesthetized with 0.15 gl
−1
 of tricaine methanesulfonate (MS-222) (Argent 124 
Chemical Laboratories, Redmond, WA, USA) and infected by intraperitoneal (i.p.) injection with 100 µl 125 
of VHSV solution (10
6
 TCID50g
-1
) (two groups of n=30). Control groups were injected with the same 126 
volume of culture medium (two groups of n=30). The mortalities were monitored for 30 days post-127 
infection (p.i.). Surviving fish (considered “resistant”) and control fish (considered “naive”) from each 128 
family were again divided into two groups and re-challenged with the same viral solution or treated with 129 
culture medium. Twenty-four hours after the second injection, five fish from each treatment and family 130 
were sacrificed, and head kidneys were removed (Fig. 1a). Thus, samples from 24 h p.i. represent the 131 
naive infected group (NI); those from 30 days p.i. correspond to the resistant control group (RC), and the 132 
resistant-infected group (RI) is represented by survivor fish re-challenged with the same viral solution. 133 
The naive control group (NC) serves as the control for each sampling point (Fig. 1b). Fish care, viral 134 
infections and fish sampling were conducted in accordance with the guidelines of the CSIC National 135 
Committee on Bioethics.  136 
 137 
RNA extraction and reverse transcription 138 
Turbot kidneys were collected in TRIzol reagent (Invitrogen) and stored at -80 °C until use. Total 139 
RNA was extracted following the manufacturer´s instructions, and RNA was purified using the RNeasy 140 
mini kit (Qiagen) after DNase I treatment to remove genomic DNA (RNase-free DNase set, Qiagen). The 141 
purified RNAs were quantified using a Nanodrop ND-1000 (Thermo Scientific). To generate cDNA, 142 
RNAs from five fish were pooled (2 μg of RNA per fish). Reverse transcription was performed with 143 
SuperScript III First-Strand Synthesis SuperMix for qRT-PCR (Invitrogen). 144 
 145 
Microarray analysis 146 
An 8 x 15K S. maximus Oligo Array v 1.0 was used  (AMADID 24698) (Millán et al. 2010; 147 
Hagenaars et al. 2011). In brief, this array contains 60-mers from 4,305 genes, each represented at least 148 
three times. A total of 16 microarray-8x15K slides were hybridized. RNAs from five fish per group were 149 
pooled, and their quality was assessed with a 2100 bioanalyzer (Agilent) before microarray analysis. 150 
RNA labelling (2 µg at ~50 μg/ml) and hybridization were conducted with the University of Santiago de 151 
Compostela microarray platform using Agilent one-color Gene Expression Analysis, as described 152 
previously (Millán et al. 2010), in compliance with Minimum Information about a Microarray Experiment 153 
(MIAME) standards (Brazma 2001). 154 
Signal was captured, processed and segmented using an Agilent scanner (G2565B, Agilent 155 
Technologies) by the Agilent Feature Extraction Software (v9.5) with protocol GE1-v5_95, extended 156 
dynamic range and preprocessing by the Agilent Feature Extraction v9.5.5.1. Fluorescence intensity data 157 
and quality annotations were imported into GeneSpring GX version 11.0.2 (Agilent Technologies). All 158 
control features (positive, negative, landing lights, etc.) were excluded from subsequent analyses. Prior to 159 
normalization, all intensity values lower than 1 were set to 1.0; data were normalized by percentile shifts 160 
at the 75th percentile and were filtered both by flags and by expression between the 20 and 100th 161 
percentile in the raw data. 162 
To assess differential gene expression, the normalized log intensity ratios were analyzed with a three-163 
way ANOVA and Student's t tests. The three-way ANOVA was performed in order to explore the effects 164 
of family genetic background and the response and resistance to a viral infection on the gene expression 165 
profiles (P<0.05 and fold-change ratios ≥2). Student's t tests were performed to identify genes that were 166 
differentially expressed between high- and low-mortality families (P<0.05 and fold-change ratios ≥2) 167 
using two or four biological replicates. The data presented in this publication and the MIAME-compliant 168 
information have been deposited in the NCBI´s Gene Expression Omnibus and are accesible under the 169 
accession number GSE35804.  170 
 171 
Gene expression analysis by real time PCR 172 
A group of genes was selected for RT-qPCR expression analysis to validate the results of the 173 
microarray analysis. Amplification was performed using specific primers, which were designed using 174 
Primer3 software (Rozen and Skaletsky 2000) according to known qPCR restrictions (amplicon size, Tm 175 
difference between primers, GC content and self-dimer or cross-dimer formation). The selected genes and 176 
primer sequences are shown in Table 1. Primer efficiency was validated with seven serial five-fold 177 
dilutions of cDNA and calculated from the slope of the regression line of Ct versus the relative 178 
concentration of cDNA (Pfaffl 2001). A melting curve analysis was performed to verify that no primer 179 
dimmers were amplified.  180 
Quantitative PCR assays were performed using a 7300 Real Time PCR System (Applied Biosystems). 181 
In a final volume of 25 μl, 1 μl of 5-fold diluted cDNA template was mixed with 0.5 μl of each primer (10 182 
μM) and 12.5 μl of SYBR green PCR master mix (Applied Biosystems). Amplification was performed 183 
under standard cycling conditions of 95 °C for 10 min followed by 40 cycles of 95 °C for 15 s and 60 °C 184 
for 1 min. Three technical replicates were performed in each sample. 185 
Relative gene expression levels were calculated as described by Pfaffl (2001), using elongation factor 186 
1- as housekeeping gene that was expressed constitutively (i.e., not affected by the treatment). Fold-187 
change units were calculated by dividing the normalized expression values in infected tissues by the 188 
normalized expression values in the controls.  189 
 190 
 191 
Results 192 
 193 
Mortality 194 
The results obtained in the experimental infections showed differences in susceptibility to VHSV 195 
between the six turbot families. Meanwhile, families 1 and 4 presented very low mortality rates at 30 d 196 
p.i. (3.3% ± 4.6 in both families), with families 2 and 3 showing the highest cumulative mortalities 197 
(56.5% ± 23.3 and 46.6% ± 18.8, respectively). Families 5 and 6 had intermediate sensitivity to viral 198 
infection, reaching mortality values of 26.6% (± 9.4) and 9.9% (± 4.7), respectively, at the end of the 199 
experiment (Fig. 2). Moreover, moribund and dead fish from families 2 and 3 showed external clinical 200 
signs of infection, such as haemorrhage at the base of the fins and around the eye orbit and mouth, as well 201 
as internal haemorrhage in the liver, in adipose tissue and within the muscle. No external clinical signs of 202 
infection were detected in low-mortality families (1 and 4). Thus, we chose to further study the 203 
transcriptome profile after VHSV infection in four families: two high-mortality families (families 2 and 204 
3) and two low-mortality families (families 1 and 4). 205 
 206 
 207 
Overview of transcriptome analysis 208 
Multiple statistical comparisons were performed using a three-way ANOVA in the four selected 209 
families in order to explore the effects of family genetic background (factor “Family”), the response to a 210 
viral infection at 24 h p.i. (factor “Infection”) and previous contact with the virus (factor “Resistance”), as 211 
well as the interactions among these factors, on gene expression profile. The three-way ANOVA was 212 
performed to compare gene expression in naive-infected (NI or fish treated once with VHSV), resistant 213 
controls (RC; i.e., fish treated once with VHSV and sampled 30 days p.i.) and resistant-infected (RI; i.e., 214 
survivor fish that were re-challenged with the same viral solution) groups to the expression in the naive 215 
controls group (NC) within each family. 216 
Two different comparisons were performed by Student's t test analyses considering families with 217 
similar mortality rates to be biological replicates. In the first analysis, the values obtained for each 218 
treatment group (NC, NI, RC and RI) of the high-mortality families were compared with those obtained 219 
in the same treatment group of the low-mortality families. These comparisons identified genes that were 220 
differentially expressed between high- and low-mortality families before infection (NC groups), at 24 h 221 
p.i. (NI groups), at 30 days p.i. (RC groups) and at 24 h after a re-challenge (RI groups). 222 
Student's t tests were also used to compare gene expression in the different treatment groups within 223 
the same families. In this context, the NI vs. NC and RC vs. NC comparisons were used to identify genes 224 
that were differentially expressed at 24 h and 30 d after one exposure to the virus, respectively. The genes 225 
involved in resistance to the viral infection (RI vs. NI) as well as the genes that were stimulated 24 h after 226 
a second viral exposure (RI vs. RC) were also analyzed. 227 
  228 
Three-way ANOVA  229 
The results of the three-way ANOVA analysis determined that the factor “Family” was involved in 230 
the greatest number of gene expression differences (Fig. 3). This factor was able to explain the 231 
modulation of 45.54% (261 out of 573 genes) of all differentially expressed genes. The combinations 232 
“Family-Resistance” and “Family-Infection” explained 9.59% and 8.9% of the changes, respectively. 233 
Thus, genetic background alone and in combination with the other factors was involved in the regulation 234 
of 70.33% (403 genes) of the differentially expressed genes (Fig. 3). Meanwhile, the factor “Infection” 235 
explained the differences in expression in 80 genes (13.96%), and the factor “Resistance” was only 236 
involved in 11.86% of the changes (68 genes). Only 36 genes (6.28%) were affected by the combination 237 
of these three factors (Fig. 3). Only annotated genes were taken into account in the data analysis because 238 
most of these modulated genes were not homologous to any genes in public databases. Moreover, genes 239 
with similar and consistent behaviour in both high- and low-mortality families and showing a fold-change 240 
ratio ≥2 were described. 241 
Although the factor “Family” was associated with the greatest number of differences in the 242 
transcriptome, only 19 of these genes were homologous to known sequences (7.27%), and most of them 243 
were related to metabolic processes (Supplementary Table 1). Only two genes showed different behaviour 244 
between high- and low-mortality families. The UTP-glucose-1-phosphate uridylyltransferase and the 245 
secreted trypsin-like serine protease were always significantly down-modulated in resistant families (1 246 
and 4) (Table 2). 247 
Only 14 of the 80 genes that were regulated by the factor “Infection” (17.5 %) had homology to 248 
sequences that have been described in databases (Supplementary table 1). Six of these were significantly 249 
down-modulated after infection in low-mortality families (1 and 4). Viral infection significantly reduced 250 
the expression of the 60 S ribosomal protein L21, a sex hormone-binding globulin, an aldo/keto 251 
reductase, a SPRY domain-containing protein, complement component C9 and an antimicrobial peptide 252 
precursor (Table 2). Meanwhile, the interferon-induced protein Mx2 was up-modulated by infection in 253 
both low- and high-mortality families (Table 2).  254 
Only ten of the 68 genes (14%) associated with the factor “Resistance” had previously been annotated 255 
in databases (Supplementary Table 1). Cathepsin L.1 and the interleukin-8 precursor were up-modulated 256 
in both RC and RI groups within the low-mortality families (1 and 4). Moreover, the antitrypsin-1 gene 257 
was highly down-modulated in the same families (Table 2). 258 
Only one gene was linked to the interaction of the “Family” and “Infection” factors. In this analysis, 259 
the complement component C8γ was down-regulated in the RC groups within families 1 and 4 (Table 2). 260 
The interaction of “Family” and “Resistance” factors did not significantly modify the expression of any 261 
gene in low-mortality families compared to high-mortality families (Supplementary Table 1). 262 
As expected, the interaction between the factors “Infection” and “Resistance” induced a large number 263 
of changes in the transcriptome. Approximately 60 % of the modulated genes (13 out of 22 genes) 264 
showed homology to known sequences, and 11 genes were modulated differently in high- and low-265 
mortality families (Table 2). All of the genes were down-modulated by infection in the different groups 266 
within each family (NI, RC and RI groups). The expression levels registered in low-mortality families (1 267 
and 4) were significantly much lower than those obtained in high-mortality ones (Table 2).   268 
Finally, the genes regulated by the interaction of the three factors (“Family”, “Infection” and 269 
“Resistance”) were mostly related to metabolism (Supplementary Table 1). Only 12 out of 36 genes (33.3 270 
%) showed homology to known sequences, and only three genes behaved differently between high- and 271 
low-mortality families. The hepcidin gene, a trypsin-like serine protease and a notch homolog protein 2-272 
like gene were down-modulated after infection in low-mortality families only (Table 2). Importantly, the 273 
up-modulation of virus-induced protein 5 was observed in all families, as was expected (Table 2). 274 
 275 
Student's t test analysis 276 
A large amount of information was obtained in all the different comparisons conducted with the 277 
Student's t tests. The first analysis provided information on genes that were differentially expressed 278 
between high- and low-mortality families (Table 3). When not infected (NC groups), the low-mortality 279 
families showed higher basal expression of different antimicrobial peptides (2- to 5.9-fold change) than 280 
did high-mortality families (Table 3). High-mortality families showed lower expression levels of a 281 
sodium/hydrogen exchanger protein gene (2.06 times lower), the complement component C8 gene (2.63 282 
times lower) and the butyrophilin member A1 precursor gene (4.73 times lower) (Table 3). The 283 
differences in gene expression between low- and high-mortality families at 24 h after viral infection were 284 
analyzed (NI groups). Interestingly, while the low-mortality families exhibited up-modulation of several 285 
genes (selectin P, 5-aminolevulinate synthase and arrestin domain-containing protein 2), the high-286 
mortality families exhibited a strong down-modulation of the lily-type lectin gene (21.99 times lower than 287 
low-mortality families), an alcohol dehydrogenase gene (10.77 times lower), and a myeloid-associated 288 
differentiation marker gene (6.86 times lower) (Table 3) and a weak down-regulation of other genes 289 
(prostasin-like gene, the factor B/C2B gene and the apomucin gene) (Table 3). Among the genes that 290 
were differentially expressed 30 d after viral infection (RC groups), low-mortality families showed a 291 
significant up-modulation of cathepsin L.1 and ribonuclease T (3.09- and 2.96-fold increase, respectively 292 
(Table 3)). High-mortality families still exhibited a down-modulation of the complement component C8 293 
gene (4.94 times lower), the lily-type lectin gene (4.63 times lower), the prostasin-like gene (2.7 times 294 
lower) and the apomucin gene (2.74 times lower). Moreover, two genes related to lipid metabolism were 295 
down-regulated (7-dehydrocholesterol reductase gene and the HRAS-like suppressor 2 gene) (Table 3). 296 
No differences in the gene expression profiles were registered between the surviving fish from high- and 297 
low-mortality families 24 h after the second viral infection (RI groups).  298 
The second analysis provided information on genes that were differentially expressed at 24 h and 30 299 
days p.i. (NI vs. NC and RC vs. NC, respectively), genes related to resistance (RI vs. NI) and genes that 300 
were stimulated after a second viral exposure (RI vs. RC) within either the susceptible or the resistant 301 
families (Table 4). Twenty-four hours after infection (NI vs. NC), a general down-regulation of gene 302 
expression was observed in all families (Table 4). While the changes registered in the high-mortality 303 
families ranged between 2.03 to 4.00 (fold-decrease), a much stronger down-modulation was observed in 304 
low-mortality families (ranging from 5.03 to 53.09 times lower). Low-mortality families showed the 305 
highest down-modulation of antimicrobial peptides (53.09 times lower than controls), several 306 
complement components (38.21 times lower) and the perforin gene (32.65 times lower). Moreover, other 307 
important genes were highly down-modulated, such as the warm temperature acclimation-related 65-kDa 308 
protein (WAP65) (30.37 times lower), the tributyltin binding protein type 1 (29.43 times lower) and the 309 
Ca
2+
 dependent complex C1R/C1S (17.60 times lower) (Table 4). High-mortality families showed an up-310 
modulation of factor B/C2B (2.66 times) but a generally low down-modulation of several genes involved 311 
in different metabolic pathways (prosaposin, 2-hydroxyacyl-CoA lyase 1, aminotransferases, 312 
dehydrogenases and a Na
+
/K
+
 ATPase) and in the maintenance of the ionic balance (two pore segment 313 
channel 1, solute carrier family 25 member 42 and a Na
+
/H
+
 exchanger isoform 3) (Table 4). 314 
Thirty days after infection (RC vs. NC), a significant down-modulation of the tropomyosin and 315 
troponin genes (20.43 and 11.65 times lower, respectively) and other genes such as the cytochrome P450 316 
(3.11 times lower) was observed in the low-mortality families. At this time, high-mortality families 317 
showed a significant up-modulation of matrix metallopeptidase 13 (2.27 times) and an inhibition of the 318 
apolipoprotein E1 (2.27 times lower) (Table 4). Genes related to resistance were identified by comparing 319 
the RI vs. NI datasets. In this situation, the low-mortality families showed an up-modulation of a myeloid-320 
associated differentiation marker (3.79 times) and a general inhibition of apolipoprotein A1, tributyltin-321 
binding protein type 2, an aldo-keto reductase and the WAP65. High-mortality families showed an up-322 
modulation of two-pore segment channel 1, the probable mitochondrial protein COQ10 and proline 323 
dehydrogenase 2. The expression of complement component C9 was also inhibited (2.22 times lower) 324 
(Table 4). Differential expression after a second viral infection (RI vs. RC) included an up-regulation of 325 
Mx2 and virus-induced protein 5 (3.42 and 3.13 times) in high-mortality families and a down-modulation 326 
of coagulation factors (2.77 times lower) in low-mortality families (Table 3). 327 
 328 
Validation of array results by real-time PCR 329 
Real-time PCR analysis was performed to confirm the microarray data (Fig. 4). The expression levels 330 
of five selected genes (an antimicrobial peptide, complement component C8 γ-chain, hepcidin, Mx2 and 331 
the WAP65) were measured and normalized to the expression of EF-1α, which was found to be expressed 332 
constitutively in microarray analyses. The microarray data were confirmed by real-time PCR for all 333 
genes, with the obtained expression patterns showing the same directions of response in both 334 
methodologies (Figure 4).  335 
 336 
 337 
Discussion 338 
In order to search for molecular markers linked to resistance in different families of turbot and to 339 
explore systemic gene response after VHSV infection, we performed a transcriptional analysis in low- 340 
and high-mortality families after infection. Although the effects of VHSV infection on the modulation of 341 
several immune functions and some immune-related genes have been described in different fish species 342 
including turbot (Abollo et al. 2005; Encinas et al. 2010; Jørgensen et al. 2011; Novoa et al. 2010; Tafalla 343 
et al. 2001, 2005; Tafalla and Novoa 2001), the effect of the progression of VHS disease on the global 344 
gene expression profiles of resistant and susceptible fish families remains unknown. Only one recent 345 
publication has explored the importance of several key innate immune-related genes in the increased 346 
survival observed in different families of infected rainbow trout (O. mykiss) (Jørgensen et al. 2011). 347 
As reviewed by Douglas (2006), oligonucleotide microarrays have been developed for several fish 348 
species, such as zebrafish, salmonids including the rainbow trout and the Atlantic salmon, catfish, 349 
seabream and flatfish including turbot, sole and the Japanese flounder (Aoki et al. 2011; Byon et al. 2005, 350 
2006; Cerdá et al. 2010; Douglas et al. 2007; Kurobe et al. 2005; Millán et al. 2010; Osuna-Jiménez et al. 351 
2009; Park et al. 2009). There are few well-annotated and curated flatfish EST and protein sequences 352 
available in public databases; this is one reason why a significant percentage of the genes identified in our 353 
analyses show no homology to known sequences deposited in databases. This lack of information 354 
presents a major challenge for transcriptomic analysis. To understand the importance of the differentially 355 
expressed genes obtained through our microarray analysis of natural resistance to a VHSV infection, an 356 
overview of all the changes in gene expression determined by different statistical approaches were 357 
correlated with different stages of the viral disease. 358 
In this work, infection with a turbot VHSV isolate revealed a differential susceptibility to the disease 359 
between the six families of turbot. The high levels of cumulative mortality registered in four out of six 360 
families were similar to those described previously (Brudeseth et al. 2005; Castric and de Kinkelin 1984; 361 
King et al. 2001; Snow and Smail 1999). Moreover, diseased turbot displayed external clinical signs of 362 
VHSV infection and internal lesions (Castric and de Kinkelin 1984; King et al. 2001; Ross et al. 1994; 363 
Smail 1999). We classified families 1 and 4 as “low-mortality” and families 2 and 3 as “high-mortality”. 364 
Moreover, the observed modulation of different gene expression was consistent with the development of 365 
the disease. The up-modulation of the interferon-induced Mx2 gene, the IL-8 gene and the VHSV-366 
induced protein 5 gene in the infected groups (NI and RI groups) in both high- and low-mortality families 367 
suggested a response similar to that observed in other fish species. Jørgensen et al. (2011) reported a 368 
similar up-modulation of these genes in infected trout. The importance of the Mx proteins in resistance 369 
against DNA and RNA viruses has been clearly described (Haller et al. 2007). Moreover, the up-370 
modulation of Mx2, IL-8 and VHSV-induced protein 5 after viral infection was already been reported in 371 
different fish species (Abollo et al. 2005; Fernández-Trujillo et al. 2008; O'Farrell et al. 2002; Park et al. 372 
2009; Tafalla et al. 2005; Workenhe et al. 2009). Interestingly, low-mortality families also showed a 373 
significant down-regulation of cytochrome P450 expression at 30 days after infection (RC group), 374 
suggesting that VHSV could be present inside the fish at this time; previous studies have reported that 375 
cytochrome P450 is permanently downregulated in humans during viral and bacterial infections 376 
(Armstrong and Renton 1994; Bleau et al. 2001; Morgan 1997).  377 
Our three-way ANOVA analysis showed that the factor “Family” (i.e. genetic background) explained 378 
the greatest number of variations in the gene expression profiles, highlighting the importance of the 379 
genetic background in the response to viral infection and in the degree of resistance or susceptibility of 380 
the different families of turbot. This large-scale screen of changes in mRNA expression revealed different 381 
patterns in high- and low-mortality families before and during viral infection. Similar observations in 382 
infected rainbow trout (O. mykiss) were reported by Jørgensen et al. (2011). 383 
Before the experimental infection, fish from low-mortality families showed a high expression of 384 
different antimicrobial peptides, suggesting a pre-immune state higher than that of high-mortality 385 
families, which could lead to a faster and stronger immune response after the first viral infection. The 386 
opposite situation was observed in high-mortality families, where low levels of complement component 387 
C8 and other cellular receptors (butyrophilin A1 precursor gene) could be associated with a higher 388 
susceptibility to viral infection, as has been previously described in humans (Botto et al. 2009; Cooper 389 
and Nemerow 1989; Jasin 1977; Pickering et al. 2008).  390 
The basements of the fins and the gills are the main sites of VHSV entry in bath infections (Smail 391 
1989). Mucosal secretion protects the fish against bacterial and viral aggression through different specific 392 
and non-specific immune substances on the fins, skin and other body surfaces (Palaksha et al. 2008; 393 
Salinas et al. 2011; Shephard 1994; St Louis-Cormier et al. 1984). Several mucins, prostasin proteins and 394 
lectins play an important role in limiting infectious disease (Linden et al. 2008). Interestingly, low levels 395 
of several components of the mucus, such as apomucins, a prostasin-like protein and a lily-type lectin, 396 
were registered in high-mortality families of turbot. Moreover, the keratin protein that is a major 397 
component of the fins (Saraswat and Ram 1970) and protects the fish by providing a barrier against 398 
viruses (Friedman 2006) was also down-regulated in high-mortality families. 399 
Interestingly, a down-regulation of different genes involved in the entrance of the virus into target 400 
cells was observed in low-mortality families after infection. High levels of a secreted trypsin-like serine 401 
protease have recently been shown to improve the entrance of a pseudorabies virus within the target cells 402 
(Glorieux et al. 2011). Some members of the lipocalin family, such as apolipoproteins and the scavenger 403 
receptor cysteine-rich-domain-containing protein, are also essential for virus infectivity (Hill et al. 2007; 404 
Hishiki et al. 2010; Owen et al. 2009). Park et al. (2009) also reported an increase in apolipoprotein A1 405 
after a nodavirus infection in trout. In this context, the low expression levels of all these genes in low-406 
mortality families could be an advantage, preventing the spread of the viral infection within the fish. 407 
The high- and low-mortality families also showed different gene expression profiles after VHSV 408 
infection. The low-mortality families showed a strong down-regulation of antimicrobial peptides 409 
(including the hepcidin gene), perforins (up to 53.09 and 32.65 times lower, respectively) and several 410 
components of the complement pathway. Although antimicrobial peptides have been described to possess 411 
antiviral activity in fish (Chia et al. 2010; Falco et al. 2009; Pasupuleti et al. 2011; Rajanbou and Chen 412 
2011; Wang et al. 2010; Zhou et al. 2011), it is possible that low-mortality families down-modulated 413 
these genes in favor of the expression of other genes that are important to maintain the minimal 414 
physiological functions that ensure fish survival. 415 
The anterior kidney is the most important target organ of rhabdoviral infection (Smail 1999), and 416 
infection induces extensive haemorrhages, apoptosis and necrosis in the haematopoietic tissue as well as 417 
in the renal tubules and glomeruli (Amend and Smith 1975). Normal kidney function is lost during 418 
infection, and the physiological dysfunction of the renal elements disrupts electrolyte balance and plasma 419 
pH. Moreover, the destruction of haematopoietic tissue also induces changes in the composition of 420 
cellular components of the blood (Amend and Smith 1974; Watson et al. 1956). The ultimate cause of 421 
death is usually acute kidney failure and loss of osmoregulation. The expression of several proteins has 422 
been used to assess renal function and monitor the course of progression of renal diseases in humans. 423 
Among them, levels of retinol-binding protein (Ayatse 1991), microglobulin (Miyata et al. 1998; 424 
Narisawa et al. 1998; Pless-Mulloli et al. 1998), the tributyltin-binding proteins (Post et al. 2010) and the 425 
apolipoproteins (Boes et al. 2006) have been shown to increase during renal disease. In our experimental 426 
infections, the low-mortality families (in contrast to the high-mortality ones) showed a strong down-427 
modulation of these three genes at all sampling points (24 h p.i., 30 d p.i. and 24 h after a second viral 428 
exposure), suggesting the maintenance of kidney structure and function. The changes in ion channel gene 429 
expression did not show a specific expression pattern, likely because the ion transporters along the 430 
nephron are very dynamic and respond quickly to fluctuations in electrolytes (McDonough et al. 2003). 431 
Moreover, the high levels of expression of the myeloid-associated differentiation marker gene in low-432 
mortality families at 30 d p.i. also suggest the normal haematopoietic function of this tissue because 433 
VHSV is able to replicate in kidney macrophages (Tafalla et al. 1998). 434 
A small number of immune-related genes were obtained in our analysis, most probably because the 435 
only available oligo-array employed in our analysis was constructed using spleens from Aeromonas 436 
salmonicida-challenged fish (Millán et al. 2010). Fibrinogens are acute phase proteins (APPs) that are 437 
involved in blood coagulation, immune response and inflammation (Baumann and Gauldie 1994). 438 
Previous studies that evaluated fibrinogen levels following viral infections (Byon et al. 2005; Park et al. 439 
2009) and after vaccination (Keiser et al. 2009) suggested that fibrinogen expression levels are high 440 
during systemic inflammatory response (Xie et al. 2009). Therefore, fibrinogen expression depends on the 441 
time after the viral infection, as well as the virus itself. Our oligo-array indicated that several genes 442 
involved in coagulation (fibrinogen  and γ chains and the coagulin factor II) are down-regulated in the 443 
low-mortality families, suggesting an alternative role for these components. This extreme down-444 
regulation is possible given that neither external clinical signs nor haemorrhagic lesions were detected in 445 
the low-mortality families. Moreover, the low level of fibrinogen could reduce the likelihood of 446 
opportunistic bacterial infection because the fibrinogen molecule can act as a receptor for the attachment 447 
of bacteria to virus-infected cells (Sanford et al. 1982). It is important to remember that antimicrobial 448 
peptides, complement components and other related antibacterial genes were inhibited in low-mortality 449 
families. The WAP65 was highly down-regulated in the low-mortality families (up to 275.46 times lower 450 
in family 4). WAP65 plays an important role in the acclimation to warm temperature and in immune 451 
response after bacterial and viral infections (Park et al. 2009; Sarropoulou et al. 2010; Sha et al. 2008). A 452 
recent study in ayu (Plecoglossus altivelis) revealed that WAP65 is involved in the activation of the 453 
complement system through component C3 (Shi et al. 2011). A general down-regulation of the 454 
complement components was registered in both resistant and susceptible families after VHSV infection. 455 
Therefore, our results could suggest a regulation of the complement system by WAP65 in low-mortality 456 
families after infection. As described by Shi et al. (2011), WAP65 might be involved in fighting 457 
microbiological infections through the activation of the complement system. 458 
In general, the expressions of different genes involved in the metabolism of sugars, lipids and proteins 459 
were decreased in both high- and low-mortality families. Low-mortality families showed a strong down-460 
modulation of several genes related to sugar metabolism, while the high-mortality families showed a less 461 
dramatic down-regulation of genes related to lipid metabolism. Although the relationship between 462 
glucose and lipid metabolism and viral infection is not clear (Anty et al. 2007; Bernard et al. 1988), 463 
Encinas et al. (2010) reported a general up-regulation of glycolytic enzymes in susceptible zebrafish after 464 
VHSV infection. The different result observed here could be the consequence of a combined response 465 
between the change in metabolic rates induced by viral infection and the “natural predisposition of the 466 
resistant families to reduce the metabolic rates to inhibit the spread of the disease. The importance of 467 
metabolic regulation in the VHSV susceptibility of different families of turbot cannot be well explained, 468 
but these observations highlight a dramatic difference in metabolic requirements between the two family 469 
groups (high and low mortality). 470 
In summary, the present work confirms that the mechanisms by which particular species and/or 471 
populations can resist a pathogen(s) are complex and multifactorial. Taking into account all of the data 472 
described in this work, the final consequence of the infection (life or death) will be determined by 473 
multiple interactions between genes involved in many non-immune processes to ensure the preservation 474 
of essential physiological functions. When the vital functions are ensured, the activity of immune-related 475 
genes will be able to address infections in low-mortality families, as was described by Jørgensen et al. 476 
(2011). In this sense, families with a genetic background that improves the maintenance of kidney, heart, 477 
and liver function and stimulates genes related to inhibiting viral entrance will have more opportunities to 478 
overcome VHSV infection. The present study is an initial screen for genes of interest and provides an 479 
extensive description of the genetic basis underlying the differences between turbot families that are 480 
resistant or susceptible to VHSV infection.  481 
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 Figures and Tables 
 
Fig. 1 Design of the experimental infections for microarray analysis (A) and to analyze the fish immune 
response to the viral infection process over time (B). 
 
 
 
 
 
 
 
 Fig. 2 Cumulative mortalities obtained in the six turbot families at 30 d p.i. with VHSV. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Fig. 3 Venn diagram based on three-way ANOVA analysis, showing the effects of family genetic 
background (factor “Family”), response at 24 h (factor “Infection”) and response at 30 d (factor 
“Resistance”) after VHSV infection on the changes observed in the gene expression profiles. 
 
 
 
 
 
 
 
 
 Fig. 4 Validation of microarray results by RT-qPCR. Families 1 and 2 were selected as the resistant and 
susceptible families, respectively. The expression levels of the selected genes (an antimicrobial peptide, 
the complement component C8 γ-chain, hepcidin, Mx2 and the 65-kDa warm temperature acclimation 
protein) were normalized to the housekeeping gene EF-1. 
 
Table 1 Primers used for RT-qPCR 
 
 
Gene Primer Sequence (5'-3') 
Antimicrobial peptide AMP-F  ATG AAG ACT CTC ACC GTT GC 
 AMP-R  TTC TGT CTG TTA CTC GGC ATC 
   
Complement component C8-γ  C8g-F  CAC AAA CAG GGC AAG ACA AC 
 C8g-R  GTA GGT GGG GAA AGG GAA GA 
   
Hepcidin Hep-F  CGA GTC ACA TCA GGC AGA AG  
 Hep-R  TGC GGG TTA TCC TCA GAA CT 
   
Warm temperature acclimation protein 65 kDa Wap65-F GTT AGA CGC CAT CAC CAC TG 
 Wap65-R CGC ATG TAG ACT GGA CCT GA 
   
Mx2 Mx2-F  CTG CCA GAT GCT TCA GGA TA 
 Mx2-R  TGC AAC CAA TGT CCA AGT TC 
   
Elongation factor 1-α  EF1a-F  GGAGGCCAGCTCAAAGATGG    
  EF1a-R  ACAGTTCCAATACCGCCGATTT  
Table 2 Selection of differentially expressed genes determined by three-way ANOVA analysis using P<0.05 and a fold-change ratio equal or greater than two. Only genes 
with homology to any known sequence in public databases and showing similar and consistent behavior between low- and high-mortality families (LM and HM, respectively) 
are presented. Fold-change ratios lower than two are not represented 
 FAMILY 1 (LM) FAMILY 2 (HM) FAMILY 3 (HM) FAMILY 4 (LM) 
Factor "FAMILY" NI/NC RC/NC RI/NC NI/NC RC/NC RI/NC NI/NC RC/NC RI/NC NI/NC RC/NC RI/NC 
UTP-glucose-1-phosphate uridylyltransferase -3,58 -2,54 -6,49     -3,29   -3,60   -9,96 -4,58 -16,77 
Secreted trypsin-like serine protease   -2,57 -3,16             -6,30 -2,26 -12,65 
Factor "INFECTION"         
60S ribosomal protein L21  -4,33 -6,56 -8,25     -3,29       -19,95 -4,20 -32,73 
Sex hormone-binding globulin  -6,04 -6,53 -8,27     -2,25 2,41     -51,83 -7,93 -69,56 
Aldo/keto reductases, related to diketogulonate reductase   -2,49 -4,02             -6,06 -3,63 -6,63 
SPRY domain containing protein   -2,35 -2,23             -22,41 -4,78 -33,48 
Complement component C9 -6,06 -8,88 -8,65     -2,07       -35,51   -33,70 
Antimicrobial peptide precursor  -17,58 -24,10 -22,48   -4,91 -13,85       -160,35   -248,15 
Mx type 2 3,34 2,32 5,03 17,66   3,24     2,78     2,07 
Factor "RESISTANCE"         
Cathepsin L.1   4,12 4,17 2,81             2,50   
Interleukin-8 precursor   3,69 28,59           2,18   2,13 2,26 
Alpha-1-antitrypsin -8,72 -19,05 -14,52 -2,26 -3,23 -6,87 3,01   -2,03 -43,41 -6,99 -103,18 
Factors "FAMILY and INFECTION"         
Complement component C8 gamma    -2,26               -4,69 -2,13 -4,83 
Factors "INFECTION and RESISTANCE"         
Apolipoprotein a  -3,16 -2,09 -4,89             -9,63 -4,60 -16,57 
Alpha-1-microglobulin -5,03 -6,95 -5,46     -2,38       -33,32 -6,92 -82,90 
Retinol-binding like protein  -3,94 -2,92 -8,66     -2,06 2,28     -10,54 -5,86 -26,63 
Scavenger receptor cysteine rich domain containing protein -2,47 -2,05 -3,05             -4,58 -3,28 -7,15 
Tributyltin binding protein type 1 -11,27 -21,28 -19,47   -5,85 -15,54 2,12   -2,02 -76,85 -3,89 -156,95 
Fibrinogen alpha chain -12,41 -22,25 -19,94 -2,16 -3,49 -6,29 2,66     -93,22 -4,42 -115,41 
Fibrinogen gamma chain   -24,87 -30,58   -2,88 -5,40 2,71     -100,87 -5,39 -178,39 
Serpin peptidase inhibitor, clade A, member 10  -6,69 -8,14 -9,89     -2,07 2,29     -54,42 -6,09 -76,16 
Serine/cysteine proteinase inhibitor  -10,08 -17,63 -14,28 -2,70 -3,25 -7,03 2,57 -2,19 -2,36 -60,17 -10,39 -151,30 
Warm temperature acclimation protein 65-2  -11,53 -30,63 -20,86 -2,09 -5,22 -23,95 2,22   -2,01 -179,53 -4,71 -275,46 
MSSP multi-domain protein -10,68 -44,85 -16,42 -2,25 -5,22 -11,14   -2,85 -3,69 -198,20 -9,78 -567,94 
Factors "FAMILY and INFECTION and RESISTANCE"         
Hepcidin precursor -2,61   -4,26             -9,27 -2,21 -17,27 
Secreted trypsin-like serine protease     -3,34             -2,85 -3,01 -6,51 
Neurogenic locus notch homolog protein 2-like -3,63 -5,11 -6,11   -2,09 -2,56       -41,47 -3,14 -44,63 
Virus-induced protein 5   2,03 9,60 4,92   2,49     3,24     2,68 
 
Table 3 Differences in the gene expression profiles between high- and low-mortality families of turbot to VHSV as determined by Student's t test analysis (P<0.05). Genes 
represented had a fold-change ratio ≥2 
  
Modulated genes in high-mortality families  Modulated genes in low-mortality families  
Gene name Fold change Gene name Fold change 
Naive control: basal 
gene expression 
before infection 
Sodium/hydrogen exchanger isoform 3  -2.06 Antimicrobial peptide NK-lysin precursor  +2.01 
Bone morphogenetic protein 4  -2.19 Antimicrobial peptide precursor   +5.95 
Protein tyrosine phosphatase receptor type Q   -2.56     
Complement component C8 gamma  -2.63     
Butyrophilin subfamily 1 member A1 precursor  -4.73     
  Gene name Fold change Gene name Fold change 
Naïve-infected: early 
gene expression after 
24 h p.i. 
Phosducin-like protein 3   -2.00 TT ORF1 domain containing protein  +2.03 
S100-A1   -2.07 Selectin P  +2.17 
Prostasin-like  -2.08 Two pore segment channel 1  +2.20 
Factor B/C2B  -2.22 5-Aminolevulinate synthase  +2.21 
Apomucin  -2.71 Betaine aldehyde dehydrogenase   +2.40 
Myeloid-associated differentiation marker  -6.86 Arrestin domain-containing protein 2   +2.61 
Alcohol dehydrogenase class VI   -10.77     
Lily-type lectin   -21.99     
  Gene name Fold change Gene name Fold change 
Resistant control: late 
gene expression after 
30 days p.i. 
7-Dehydrocholesterol reductase   -2.36 Golgi-associated plant pathogenesis-related protein 1   +2.11 
15-Hydroxyprostaglandin dehydrogenase   -2.41 Exonuc X-T domain containing protein   +2.96 
Cytochrome b ascorbate-dependent protein 3   -2.43 Cathepsin L1   +3.09 
Prostasin-like  -2.70     
Apomucin  -2.74     
DUF566 domain containing protein   -4.52     
Lily-type lectin   -4.63     
HRAS-like suppressor 2   -4.69     
Cationic trypsin-3 precursor  -4.86     
Complement component C8 gamma  -4.94     
Keratin 15   -5.56     
 
 
 
 
Table 4 Differences in the gene expression profiles at 24 h p.i., 30 d p.i. and 24 h after a second infection with VHSV in high- and low-mortality families of turbot, identified 
through a Student's t test analysis (P<0.05). Genes represented had a fold-change ratio ≥2 
  
Modulated genes in high-mortality families  Modulated genes in low-mortality families  
Gene name Fold change Gene name Fold change 
NI vs. NC  
Factor B/C2B  +2.66 Fatty acid binding protein H6-isoform  -2.50 
O-Fucosylpeptide 3-beta-N-acetylglucosaminyltransferase   -2.03 Fructose-bisphosphate aldolase A   -5.03 
Prosaposin   -2.00 Apolipoprotein A1   -7.29 
2-hydroxyacyl-CoA lyase 1   -2.02 Ca2+ dependent complex C1R/C1S subunit  -17.60 
TT ORF1 domain containing protein  -2.02 Tributyltin binding protein type 1   -29.43 
Heat shock protein 90   -2.08 Warm temperature acclimation-related 65 kDa protein   -30.37 
RING finger protein 10   -2.18 Perforin  -32.65 
Ca2+-binding actin-bundling protein fimbrin/plastin  -2.19 Complement regulatory plasma protein  -38.21 
Alkaline phosphatase  -2.21 Antimicrobial peptide precursor   -53.09 
Similar to protein tyrosine phosphatase, receptor Q   -2.24     
Two pore segment channel 1  -2.24     
Histidyl-tRNA synthetase   -2.24     
SEC6-like 1  -2.37     
5-Aminolevulinate synthase  -2.40     
4-Aminobutyrate aminotransferase  -2.42     
Carnitine octanoyltransferase  -2.47     
DUF2457 multi-domain protein  -2.64     
Permeases of the major facilitator superfamily   -2.67     
Similar to hepatitis B virus x associated protein   -2.71     
Butyrophilin subfamily 1 member A1 precursor   -2.71     
Sodium potassium ATPase alpha subunit  -2.82     
Solute carrier family 25 member 42  -2.95     
Proline dehydrogenase (oxidase) 2  -3.30     
Betaine aldehyde dehydrogenase   -3.74     
Sodium/hydrogen exchanger isoform 3  -4.00     
  Gene name Fold change Gene name Fold change 
RC vs. NC  
Matrix metallopeptidase 13  +2.27 Cytochrome P450  -3.11 
Apolipoprotein E1   -2.27 Fructose-bisphosphate aldolase A   -3.95 
    Skeletal muscle atypical fast troponin T isoform 1  -11.65 
    Tropomyosin 3   -20.43 
  Gene name Fold change Gene name Fold change 
RI vs. NI 
WD repeat domain 23   +2.10 Myeloid-associated differentiation marker  +3.79 
Two pore segment channel 1  +2.24 Aldo-keto reductase family 1, member A1a   -2.06 
Probable mitochondrial protein COQ10  +2.73 Chloride channel CLC-5   -2.07 
Proline dehydrogenase (oxidase) 2  +2.94 Apolipoprotein A1   -2.22 
Complement component C9   -2.22 Tributyltin binding protein type 2   -2.25 
    Apolipoprotein A1   -2.36 
    MID1 interacting G12-like protein  -2.98 
    Warm temperature acclimation-related 65 kDa protein   -3.25 
   Gene name Fold change Gene name Fold change 
RI vs. RC 
Mx type 2  +3.42 Pancreatic carboxypeptidase A1   -2.03 
Virus-induced protein 5   +3.13 Coagulin factor II   -2.77 
Exonuc X-T domain containing protein   +2.73     
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Supplementary table 1 Differentially expressed genes determined by 3-way ANOVA analysis using P<0.05 and a fold-change ratio equal or greater than two. Only genes 
with homology to any known sequence in public databases are presented between low- and high-mortality families (LM and HM, respectively). Fold-change ratios lower than 
two are not represented. The selected genes represented in table 1 are highlighted. 
Factor “FAMILY” FAMILY 1 (LM) FAMILY 2 (HM) FAMILY 3 (HM) FAMILY 4 (LM) 
 NI/NC RC/NC RI/NC NI/NC RC/NC RI/NC NI/NC RC/NC RI/NC NI/NC RC/NC RI/NC 
UTP-glucose-1-phosphate uridylyltransferase -3,58 -2,54 -6,49     -3,29   -3,60   -9,96 -4,58 -16,77 
Secreted trypsin-like serine protease   -2,57 -3,16             -6,30 -2,26 -12,65 
Catechol-O-methyltransferase domain-containing protein 1     2,19                   
JAK3 tyrosine kinase     2,62                   
C1q domain containing protein                       2,02 
Cationic trypsin-3 precursor             -2,19   -2,03   -3,78   
MAPEG domain containing protein                     2,03   
Apomucin                 -2,03       
CDC42 small effector 1     2,48                   
Cytochrome c oxidase polypeptide precursor     -2,08                   
Novel protein similar to H.sapiens platelet glycoprotein Ib beta chain                 2,07       
A type IV collagen                   2,07     
Polyadenylate-binding protein 1A                     -2,08 -2,35 
Transforming, acidic coiled-coil containing protein 3     2,18                   
Growth factor independent 1                 2,31 -2,38     
Probable oxidoreductase     -2,80             2,25     
HRAS-like suppressor 2        -2,07             -3,41   
ADP-ribosylation factor-like protein 8B     2,60                   
Urocanase domain containing 1     -2,63                   
  
 
 
                        
Factor “INFECTION” FAMILY 1 (LM) FAMILY 2 (HM) FAMILY 3 (HM) FAMILY 4 (LM) 
 NI/NC RC/NC RI/NC NI/NC RC/NC RI/NC NI/NC RC/NC RI/NC NI/NC RC/NC RI/NC 
60S ribosomal protein L21  -4,33 -6,56 -8,25     -3,29       -19,95 -4,20 -32,73 
Sex hormone-binding globulin  -6,04 -6,53 -8,27     -2,25 2,41     -51,83 -7,93 -69,56 
Aldo/keto reductases, related to diketogulonate reductase   -2,49 -4,02             -6,06 -3,63 -6,63 
SPRY domain containing protein   -2,35 -2,23             -22,41 -4,78 -33,48 
Complement component C9 -6,06 -8,88 -8,65     -2,07       -35,51   -33,70 
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Antimicrobial peptide precursor  -17,58 -24,10 -22,48   -4,91 -13,85       -160,35   -248,15 
Mx type 2 3,34 2,32 5,03 17,66   3,24     2,78     2,07 
Cytochrome P450 -2,03   -2,84           -2,04       
Ca2+-dependent lipid-binding protein, contains C2 domain       -3,22       -2,24       -2,07 
Enolase 3-1       -2,44       -2,18     -2,30 -2,45 
Galactoside-binding soluble lectin 9     4,85 2,15                 
Chymotrypsinogen 1                   -74,41 -8,71 -111,92 
Ifi-6-16 domain containing protein       2,32                 
Serine-pyruvate aminotransferase/archaeal aspartate aminotransferase     -2,19                   
                          
Factor “RESISTANCE” FAMILY 1 (LM) FAMILY 2 (HM) FAMILY 3 (HM) FAMILY 4 (LM) 
 NI/NC RC/NC RI/NC NI/NC RC/NC RI/NC NI/NC RC/NC RI/NC NI/NC RC/NC RI/NC 
Cathepsin L.1   4,12 4,17 2,81             2,50   
Interleukin-8 precursor   3,69 28,59           2,18   2,13 2,26 
Alpha-1-antitrypsin -8,72 -19,05 -14,52 -2,26 -3,23 -6,87 3,01   -2,03 -43,41 -6,99 -103,18 
Complement component C3-1         -3,56       -2,31 -6,10 -3,18 -12,97 
Prosaposin                     2,62 2,57 
BRCA1-associated RING domain protein 1     2,17                   
V-set domain containing protein   -2,18                 2,65 3,43 
Hypothetical LOC796684    -2,54 -2,45                   
hATC domain containing protein     -2,28                   
N-acetylgalactosamine kinase   2,29 4,72                   
                          
             
             
Factors “FAMILY and INFECTION” FAMILY 1 (LM) FAMILY 2 (HM) FAMILY 3 (HM) FAMILY 4 (LM) 
 NI/NC RC/NC RI/NC NI/NC RC/NC RI/NC NI/NC RC/NC RI/NC NI/NC RC/NC RI/NC 
Complement component C8 gamma    -2,26               -4,69 -2,13 -4,83 
Glyco-transf 64 multi-domain protein       -2,44                 
Novel protein       -2,55   -2,35     2,33       
CREB binding protein        -2,82                 
Exo-endo phos domain containing protein       -2,00           -8,27 -3,49 -10,29 
LSU rRNA       -2,25   -2,15             
Myosin heavy chain       -2,37   -2,25             
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Factors “FAMILY and RESISTANCE” FAMILY 1 (LM) FAMILY 2 (HM) FAMILY 3 (HM) FAMILY 4 (LM) 
 NI/NC RC/NC RI/NC NI/NC RC/NC RI/NC NI/NC RC/NC RI/NC NI/NC RC/NC RI/NC 
Transglutaminase 2, C polypeptide  12,03     16,38   -2,34 4,72 2,62     2,61 -4,54 
Actin-related protein 2/3 complex subunit 3     2,39                   
                          
                          
                          
                          
                          
                          
                          
                          
                          
                          
Factors “INFECTION and RESISTANCE” FAMILY 1 (LM) FAMILY 2 (HM) FAMILY 3 (HM) FAMILY 4 (LM) 
 NI/NC RC/NC RI/NC NI/NC RC/NC RI/NC NI/NC RC/NC RI/NC NI/NC RC/NC RI/NC 
Apolipoprotein a  -3,16 -2,09 -4,89             -9,63 -4,60 -16,57 
Alpha-1-microglobulin -5,03 -6,95 -5,46     -2,38       -33,32 -6,92 -82,90 
Retinol-binding like protein  -3,94 -2,92 -8,66     -2,06 2,28     -10,54 -5,86 -26,63 
Scavenger receptor cysteine rich domain containing protein, group B -like  -2,47 -2,05 -3,05             -4,58 -3,28 -7,15 
Tributyltin binding protein type 1 -11,27 -21,28 -19,47   -5,85 -15,54 2,12   -2,02 -76,85 -3,89 -156,95 
Fibrinogen alpha chain -12,41 -22,25 -19,94 -2,16 -3,49 -6,29 2,66     -93,22 -4,42 -115,41 
Fibrinogen, gamma polypeptide    -24,87 -30,58   -2,88 -5,40 2,71     -100,87 -5,39 -178,39 
Serpin peptidase inhibitor, clade A (antitrypsin), member 10  -6,69 -8,14 -9,89     -2,07 2,29     -54,42 -6,09 -76,16 
Serine/cysteine proteinase inhibitor  -10,08 -17,63 -14,28 -2,70 -3,25 -7,03 2,57 -2,19 -2,36 -60,17 -10,39 -151,30 
Warm temperature acclimation protein 65-2  -11,53 -30,63 -20,86 -2,09 -5,22 -23,95 2,22   -2,01 -179,53 -4,71 -275,46 
MSSP multi-domain protein -10,68 -44,85 -16,42 -2,25 -5,22 -11,14   -2,85 -3,69 -198,20 -9,78 -567,94 
Galectin-9     5,60 2,30                 
Placental growth factor-like  -2,40   -3,44 -2,11 -2,02 -4,16         -2,25   
                          
             
             
Factors “FAMILY and INFECTION and RESISTANCE” FAMILY 1 (LM) FAMILY 2 (HM) FAMILY 3 (HM) FAMILY 4 (LM) 
 NI/NC RC/NC RI/NC NI/NC RC/NC RI/NC NI/NC RC/NC RI/NC NI/NC RC/NC RI/NC 
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Hepcidin precursor -2,61   -4,26             -9,27 -2,21 -17,27 
Secreted trypsin-like serine protease     -3,34             -2,85 -3,01 -6,51 
Neurogenic locus notch homolog protein 2-like -3,63 -5,11 -6,11   -2,09 -2,56       -41,47 -3,14 -44,63 
Virus-induced protein 5   2,03 9,60 4,92   2,49     3,24     2,68 
Fructose-bisphosphate aldolase     -2,36                   
Glyceraldehyde 3-phosphate dehydrogenase     -2,56                   
V-set domain containing protein                       2,01 
Cytochrome P450     -2,56   ,           -2,18   
LSU rRNA     -2,66                 -2,27 
Ribonucleoside-diphosphate reductase subunit M2                     -2,13   
RNA-binding proteins (RRM domain)                       -2,16 
Tryptophan 2,3-dioxygenase           -2,07     -2,15   -2,33 -4,95 
 
 
 
 
